atorvastatin Articles
Tokyo pharma stocks - week to August 9
16 August 2004
Sankyo sales down but profits leap 60%
9 August 2004
Stock Commentary - New York
2 August 2004
Roche offer to New Zealand research
2 August 2004
Merck & Co/S-P's Vytorin OKed by FDA
2 August 2004
Germany: same price for generic, brand statins?
2 August 2004
Canadian web site: all drugs fake, substandard
26 July 2004
Combination drugs the new fight against generics?
19 July 2004
Indian firms pay high cost for generics
12 July 2004
Tokyo pharma stocks - week to june 14
21 June 2004
Yamanouchi deal with Pfizer restructured
7 June 2004
Sankyo's full-year revenues rise 4.6%
7 June 2004
Weak core products sales at Yamanouchi
31 May 2004
Are statins next for OTC switching?
10 May 2004
Dual Ezetrol/Zocor therapy effective
3 May 2004
AstraZeneca's Crestor is superior to Lipitor in reducing CVD risk factors in diabetics
26 April 2004
USA's Brand Institute opens European office
19 April 2004
Merck & Co/S-P's Inegy OKed in Germany
12 April 2004
Tokyo pharma stocks - week to March 22
29 March 2004
6M Americans have bought drugs on-line
29 March 2004
Pfizer's Lipitor benefits type 2 diabetics
22 March 2004
AstraZeneca's Crestor hold 6.1% of US NRx statins market
22 March 2004
Stock Commentary - New York
15 March 2004
Positive new data for AstraZeneca's Crestor
15 March 2004
Positive 9-mth results from Yamanouchi
23 February 2004
Pfizer's Caduet gets OK from FDA
9 February 2004
Sankyo's Mevalotin retains number one spot in Japan
2 February 2004
Stock Commentary - New York
5 January 2004
World retail drug sales grew 8% in year to November 2003, says IMS
30 November 2003
Australia/US trade deal stumbles over PBS
15 December 2003
Boost for Pfizer's Lipitor in first head-to-head statin study
24 November 2003
Yamanouchi in line with revised forecast
24 November 2003
Canadian Rx prices "33%-80% less than in USA"
17 November 2003
US FDA seizes "potentially dangerous" drugs from repackager
22 September 2003
US FDA introducing new measures to track bogus drugs
22 September 2003
Attack on US pharma "smokescreen"
18 August 2003
Stock Commentary - Tokyo
30 June 2003
Tokyo pharma stocks - week to June 23
30 June 2003
New study shows companies' licensing successes
30 June 2003
Varenicline, another Pfizer blockbuster?
30 June 2003
Pfizer reins in 2003 forecast, raises 2004
23 June 2003
Pfizer takes steps over counterfeit Lipitor
9 June 2003
Fake Lipitor recalled in USA
2 June 2003
Yamanouchi's FY2003 operating income up 12%
26 May 2003
Yamanouchi forecasts record operating profit
21 April 2003
Stock Commentary - Tokyo
14 April 2003
Tokyo pharma stocks - week to April 7
14 April 2003
Update - AstraZeneca 's Crestor: ACC studies
7 April 2003
First Euro launch for Crestor in Netherlands
10 March 2003
Pfizer takes on India's Ranbaxy over Lipitor
3 March 2003
First launch, in Canada, for AstraZeneca's superstatin Crestor
24 February 2003
S&P confirms Pfizer's AAA credit rating
24 February 2003
Singapore first Asian market for Cialis
24 February 2003
Stock Commentary - New York
19 August 2002
10 most effective US DTC television ads
5 August 2002
Tokyo pharma stocks - week to July 15
22 July 2002
Stock Commentary - Europe
22 July 2002
Pfizer's 2nd-qtr net income rises 10%
22 July 2002
New Crestor results reinforce profile
15 July 2002
Stock Commentary - New York
17 June 2002
Tokyo pharma stocks - week to June 10
17 June 2002
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
